INNOVATE BIOPHARMACEUTICALS, INC. Uncategorized Contracts & Agreements
16 Contracts & Agreements
- Description of the Companys Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 28, 2023)
- Form of RDD Pharma Ltd. Notice of Option Grant (Filed With SEC on August 13, 2020)
- Side Letter, dated May 1, 20202, between Amunix Pharmaceuticals, Inc. and Naia Rare Diseases, Inc (Filed With SEC on August 13, 2020)
- Form of Company Support Agreement by and among Innovate Biopharmaceuticals, Inc. and RDD Pharma Ltd (Filed With SEC on May 4, 2020)
- Description of the Companys Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 20, 2020)
- Engagement Letter, dated April 26, 2019, between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 1, 2019)
- Sublicense Agreement, dated February 19, 2016, between Innovate Biopharmaceuticals Inc. (now IB Pharmaceuticals Inc.) and Alba Therapeutics Corporation (Filed With SEC on March 14, 2018)
- SUPPORT AGREEMENT (Filed With SEC on July 6, 2017)
- SUPPORT AGREEMENT (Filed With SEC on July 6, 2017)
- Contract Manufacturer AGREEMENT SDJ Technologies, Inc. / Monster Digital (Filed With SEC on June 24, 2016)
- SPECIMEN UNIT CERTIFICATE (Filed With SEC on April 20, 2016)
- MONSTER DIGITAL,INC. INCORPORATEDUNDER THE LAWS OF THE STATE OF DELAWARE (Filed With SEC on April 20, 2016)
- FACTORING AGREEMENT (Filed With SEC on December 11, 2015)
- TRADEMARKLICENSE AGREEMENT (Filed With SEC on December 11, 2015)
- AIR COMMERCIAL REAL ESTATE ASSOCIATION STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANTLEASE - NET (Filed With SEC on November 10, 2015)
- AMENDMENT NO. 4 TO TRADEMARK.LICENSE AGREEMENT (Filed With SEC on November 10, 2015)
